Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Lilly's study showed that more patients treated with Zepbound had reductions in body weight of at least 10%, 15%, 20%, and 25% than those treated with Wegovy, while they also achieved a greater ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

From late 2020 to the summer of 2024, Eli Lilly ... Mounjaro, Zepbound, and Jardiance in the cardiometabolic category, Taltz in immunology, and Verzenio in oncology are the future of Lilly ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

Detailed price information for Flutter Entertainment Plc (FLUT-N) from The Globe and Mail including charting and trades.

It used to be that Chinese drug development was largely about creating "me too" drugs for the local market. But over the past ...

Our writer thinks these two shares are well worth checking out for investors targeting a growing stream of passive income ...